Sphera Funds Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Sell |
105,677
-12,403
| -11% | -$856K | 1.71% | 12 |
|
|
2025
Q1 | $8.2M | Buy |
118,080
+20,000
| +20% | +$1.39M | 1.89% | 12 |
|
|
2024
Q4 | $8.44M | Buy |
98,080
+20,000
| +26% | +$1.72M | 1.53% | 18 |
|
|
2024
Q3 | $9.3M | Hold |
78,080
| – | – | 1.48% | 19 |
|
|
2024
Q2 | $11.1M | Sell |
78,080
-5,000
| -6% | -$714K | 1.52% | 18 |
|
|
2024
Q1 | $10.7M | Sell |
83,080
-10,000
| -11% | -$1.28M | 1.5% | 21 |
|
|
2023
Q4 | $9.63M | Hold |
93,080
| – | – | 1.55% | 18 |
|
|
2023
Q3 | $8.46M | Sell |
93,080
-20,000
| -18% | -$1.82M | 1.54% | 12 |
|
|
2023
Q2 | $9.15M | Sell |
113,080
-30,000
| -21% | -$2.43M | 1.43% | 11 |
|
|
2023
Q1 | $11.4M | Hold |
143,080
| – | – | 1.9% | 9 |
|
|
2022
Q4 | $9.68M | Sell |
143,080
-449,800
| -76% | -$30.4M | 2.08% | 9 |
|
|
2022
Q3 | $29.5M | Buy |
592,880
+70,000
| +13% | +$3.49M | 4.1% | 6 |
|
|
2022
Q2 | $29.1M | Buy |
522,880
+48,080
| +10% | +$2.68M | 3.12% | 7 |
|
|
2022
Q1 | $26.4M | Buy |
+474,800
| New | +$26.4M | 3.73% | 6 |
|
|
2020
Q3 | – | Sell |
-800,000
| Closed | -$26.2M | – | 103 |
|
|
2020
Q2 | $26.2M | Sell |
800,000
-352,000
| -31% | -$11.5M | 2.46% | 7 |
|
|
2020
Q1 | $34.7M | Sell |
1,152,000
-128,000
| -10% | -$3.85M | 4.34% | 5 |
|
|
2019
Q4 | $37M | Buy |
1,280,000
+380,000
| +42% | +$11M | 3.05% | 5 |
|
|
2019
Q3 | $23.3M | Buy |
+900,000
| New | +$23.3M | 3.59% | 7 |
|
|
2019
Q2 | – | Sell |
-800,000
| Closed | -$20.9M | – | 100 |
|
|
2019
Q1 | $20.9M | Buy |
+800,000
| New | +$20.9M | 1.91% | 10 |
|